The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,428.00
Bid: 1,419.00
Ask: 1,422.00
Change: 71.00 (5.23%)
Spread: 3.00 (0.211%)
Open: 1,349.00
High: 1,428.00
Low: 1,349.00
Prev. Close: 1,357.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: New CFOs For Indivior And Costain

Fri, 20th Nov 2020 13:42

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Indivior PLC - Richmond, Virginia-based pharmaceutical firm focused on treatment of opioid dependence - Confirms Ryan Preblick as chief financial officer and board member. Preblick has been interim CFO since June, prior to which he was senior vice president for Global Financial Planning & Analysis Commercial Operations. Before Indivior, Preblik had stints at aerospace firm Honeywell International Inc and cigarette maker Altria Group Inc.

----------

Costain Group PLC - Maidenhead, England-based infrastructure construction - Hires Helen Willis as CFO and board member, effective from November 30 but joining the company this coming Monday. Willis was CFO of banknote and passport printer De La Rue PLC, leaving back in January, and before that CFO of electronic products distributor Premier Farnell PLC.

----------

London Stock Exchange Group PLC - Raffaele Jerusalmi and Andrea Sironi step down from LSEG board ahead of sale of Borsa Italiana Group to Euronext NV. LSEG notes that shareholders of Euronext approved the EUR4.33 billion deal on Friday, its own shareholders having done so already at the start of the month. The divestment of London Stock Exchange Group Holdings Italia Spa to Euronext was done to win European Commission approval for LSEG's USD27 billion acquisition of financial markets data and trading platform provider Refinitiv.

----------

Avon Rubber PLC - Wiltshire-based respiratory protection equipment manufacturer - Confirms that Bruce Thompson, non-executive chair designate, will replace David Evans as chair on December 2. Evans is retiring having served on the board since 2007. Meanwhile, Pim Vervaat will step down as non-executive director on January 29, having been named chief executive officer of Constantia Flexibles International GmbH and senior independent director of LED lighting manufacturer Luceco PLC. Hires Victor Chavez as independent non-executive director, effective from December 1. Chavez was CEO of Thales UK, part of French aerospace firm Thales SA.

----------

Renold PLC - Manchester-based supplier of industrial chains and related power transmission products - Hires Andrew Magson as non-executive director, starting December 1. Magson was finance director of building products firm Alumasc Group PLC from 2006 until this past February.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2021 12:17

Indivior lifts FY guidance as Q3 profits, revenue jump

(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.

Read more
24 Oct 2021 17:12

Sunday share tips: Light Science Technologies, Indivior

(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.

Read more
31 Aug 2021 09:38

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

Read more
11 Aug 2021 16:08

Director dealings: Indivior director ups stake

(Sharecast News) - Indivior revealed on Wednesday that non-executive director Mark Stejbach had acquired 36,000 ordinary shares in the FTSE 250-listed pharmaceuticals business.

Read more
10 Aug 2021 15:07

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

Read more
9 Aug 2021 13:03

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

Read more
5 Aug 2021 15:29

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

Read more
4 Aug 2021 14:23

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

Read more
30 Jul 2021 12:28

IN BRIEF: Indivior to commence USD100 million share repurchase program

IN BRIEF: Indivior to commence USD100 million share repurchase program

Read more
29 Jul 2021 15:37

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

Read more
29 Jul 2021 12:13

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

Read more
29 Jul 2021 08:48

Indivior launches share buyback after strong first half

(Sharecast News) - Speciality pharmaceuticals company Indivior reiterated its upgraded guidance for 2021 on Thursday, and announced the start of a $100m (£71.71m) share buyback programme, as its first-half net revenue rose to $381m from $303m year-on-year.

Read more
22 Jul 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Jul 2021 14:00

Indivior agrees new loan facilities of USD250 million maturing in 2026

Indivior agrees new loan facilities of USD250 million maturing in 2026

Read more
1 Jul 2021 10:33

Indivior agrees to reprice and extend maturity of term loan facilities

(Sharecast News) - Pharmaceutical firm Indivior said on Thursday that it had entered into an amendment to reprice and extend the maturity of $250.0m worth of term loan facilities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.